Virtual Library

Start Your Search

Filter Results:

Show Only Available Presentations

  • +

    Proffered Paper session I

    • Type: Proffered Paper session
    • Presentations: 8
    • Coordinates: 4/10/2019, 16:30 - 18:15, Room C
  • +

    Mini Oral session I

    • Type: Mini Oral session
    • Presentations: 8
    • Coordinates: 4/11/2019, 08:00 - 08:50, Room A
    • +

      113O - Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001

      08:10 - 08:15  |  Presenter: Luis Paz-Ares

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    Immunotherapy in stage IV

    • Type: Educational session
    • Presentations: 6
    • Coordinates: 4/11/2019, 09:00 - 10:30, Room B
  • +

    Lunch & Poster Display session

    • Type: Poster Display session
    • Presentations: 170
    • Coordinates: 4/11/2019, 12:30 - 13:00, Hall 1
    • +

      180TiP - An open-label, randomized, phase I/II trial of IO102 and pembrolizumab, or IO102, pembrolizumab and chemotherapy, as first-line treatment for patients with metastatic non-small cell lung cancer

      12:30 - 12:30  |  Presenter: James Spicer

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      185TiP - RATIONALE 001: Tislelizumab (BGB-A317) + concurrent chemoradiotherapy (cCRT) followed by tislelizumab monotherapy in patients (pts) with newly diagnosed locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC)

      12:30 - 12:30  |  Presenter: Luis Paz-Ares

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    ESMO-IASLC Best Abstracts

    • Type: Proffered Paper session
    • Presentations: 7
    • Coordinates: 4/11/2019, 14:45 - 16:15, Room B
  • +

    Mini Oral session II

    • Type: Mini Oral session
    • Presentations: 9
    • Coordinates: 4/11/2019, 16:40 - 17:40, Room C
    • +

      85O - Prevalence of programmed death ligand-1 (PD-L1) by demographic, disease and sample characteristics in unresectable, stage III NSCLC (PACIFIC)

      16:45 - 16:50  |  Presenter: David Planchard

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    Medscape Oncology - Industry Satellite Symposium

    • Type: Industry Satellite symposium
    • Presentations: 5
    • Coordinates: 4/12/2019, 13:00 - 14:00, Room A
    • +

      Welcome and introduction: Recent practice changing data – What do they mean in the real world?

      13:00 - 13:10  |  Presenter: Luis Paz-Ares

      • Abstract

      No abstract available for this presentation